Propel Bio Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.95M Buy
+410,175
New +$12M 4.75% 4

Other funds holding COLL

Propel Bio Management's COLL Position: Q3 2026 in Review

Propel Bio Management opened a new position in Collegium Pharmaceutical (COLL) in Q3 2026: 410,175 shares worth $8.95M. The stake represents 4.75% of the portfolio and ranks #4 among its holdings.

240 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Propel Bio Management held 410,175 shares of Collegium Pharmaceutical worth $8.95M as of Q3 2026.
  • Collegium Pharmaceutical was a new Propel Bio Management position in Q3 2026.
  • Collegium Pharmaceutical made up 4.75% of Propel Bio Management's portfolio in Q3 2026, its #4 holding.
  • 240 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Propel Bio Management's 13F filing for Q3 2026, filed 13 Nov 2026.